Search for: "B R H, Inc." Results 921 - 940 of 1,132
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Feb 2020, 2:32 pm by Kevin LaCroix
Under Items 601(b)(2) and (b)(10) of Regulation S-K, companies are able to omit confidential information in material contracts and certain other exhibits without submitting a confidential treatment request to the SEC, so long as the information is (1) not material and (2) would likely cause competitive harm to the company if publicly disclosed. [read post]
16 Jan 2009, 7:00 am
(IP Dragon) Patent strategies for foreign R&D work in China (Philip Brooks' Patent Infringement Updates) All clichés but still true: Intellectual Property Rights enforcement in China leaves room for improvement (IP Dragon) Recognition and protection of well-known trade marks (International Law Office) Revised Chinese patent law aims at quality, compulsory licensing (Intellectual Property Watch) Zen and the art of intellectual property in China (IP Dragon)  … [read post]
23 Jun 2014, 12:57 pm by Schachtman
P v Q v R ~P­­­_____ ∴ Q v R ~Q­­­_____ ∴ R Hence, the term, “iterative disjunctive syllogism. [read post]
3 Apr 2014, 12:30 pm by Abbott & Kindermann
(2) Is the adoption of an ordinance enacting a voter-sponsored initiative under Elections Code section 9214, subdivision (a), a “ministerial project” exempt from CEQA pursuant to Public Resources Code section 21080, subdivision (b)(1)? [read post]
31 Oct 2019, 5:55 pm by Kevin LaCroix
  A similar scenario is now playing out the Phillip Morris International Inc. [read post]
8 Aug 2007, 10:00 am
Sweeny, Dabagia, Donoghue, Thorne, Janes & Pagos and John H. [read post]
25 Jul 2008, 7:04 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
8 Aug 2007, 3:07 am
ince the beginning of the twentieth century, the United States has formally recognized a distinction between adult and juvenile offenders. [read post]
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’ still possible under… [read post]